Metabolic Therapy Inc. Report issue

For profit
Founded: Austin TX United States (2007)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2017
NCT03038282
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

chromium trichloride (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2